Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PGAC
11601
Pantages Capital Acquisition Corp
PGAC
$119M
| $156K | ﹤0.01% |
+14,896
| New | +$156K |
2026 Q1
0 quarters
|
|
11602
Bioventus
BVS
$897M
| $156K | ﹤0.01% |
17,085
-43,840
| -72% | -$368K |
2025 Q4
1 quarter
|
|
11603
CALL
Rezolute
RZLT
$388M
| $156K | ﹤0.01% |
51,100
-76,000
| -60% | -$228K |
2024 Q2
7 quarters
|
|
|
OKUR
11604
OnKure Therapeutics
OKUR
$104M
| $156K | ﹤0.01% |
37,587
-185,538
| -83% | -$573K |
2023 Q2
11 quarters
|
|
|
USAX
11605
Tradr 2X Long USAR Daily ETF
USAX
$5.15M
| $156K | ﹤0.01% |
+11,884
| New | +$314K |
2026 Q1
0 quarters
|
|
|
KLC
11606
PUT
KinderCare Learning Companies
KLC
$220M
| $156K | ﹤0.01% |
70,700
-11,900
| -14% | -$44.8K |
2024 Q4
5 quarters
|
|
11607
Coffee Holding Co
JVA
$22.7M
| $155K | ﹤0.01% |
36,578
+392
| +1% | +$1.39K |
2025 Q3
2 quarters
|
|
11608
Rimini Street
RMNI
$396M
| $155K | ﹤0.01% |
47,272
-167,491
| -78% | -$581K |
2024 Q3
6 quarters
|
|
11609
CALL
Mizuho Financial
MFG
$132B
| $155K | ﹤0.01% |
19,500
+9,400
| +93% | +$79.6K |
2025 Q4
1 quarter
|
|
|
SLSR
11610
CALL
Solaris Resources
SLSR
$1.18B
| $154K | ﹤0.01% |
+18,000
| New | +$166K |
2026 Q1
0 quarters
|
|
|
OSG
11611
PUT
Octave Specialty Group
OSG
$207M
| $154K | ﹤0.01% |
33,200
-53,800
| -62% | -$308K |
2020 Q4
21 quarters
|
|
|
CORD
11612
T-REX 2X Inverse CRWV Daily Target ETF
CORD
$22.4M
| $154K | ﹤0.01% |
+10,174
| New | +$191K |
2026 Q1
0 quarters
|
|
|
ONDU
11613
PUT
Tradr 2X Long ONDS Daily ETF
ONDU
$11.7M
| $153K | ﹤0.01% |
+4,500
| New | +$253K |
2026 Q1
0 quarters
|
|
|
CCRN
11614
CALL
DELISTED
Cross Country Healthcare
CCRN
| $153K | ﹤0.01% |
16,300
-77,100
| -83% | -$690K |
2025 Q3
2 quarters
|
|
|
XXRP
11615
PUT
Teucrium 2x Long Daily XRP ETF
XXRP
$157M
| $153K | ﹤0.01% |
3,990
-530
| -12% | -$35.6K |
2025 Q3
2 quarters
|
|
|
CURR
11616
Currenc Group
CURR
$348M
| $153K | ﹤0.01% |
+58,345
| New | +$115K |
2026 Q1
0 quarters
|
|
11617
CALL
Arcturus Therapeutics
ARCT
$370M
| $153K | ﹤0.01% |
19,800
-100,900
| -84% | -$736K |
2020 Q1
24 quarters
|
|
|
PEW
11618
PUT
GrabAGun Digital Holdings
PEW
$57M
| $152K | ﹤0.01% |
50,600
-1,900
| -4% | -$5.75K |
2025 Q3
2 quarters
|
|
|
BTGO
11619
PUT
BitGo Holdings
BTGO
$867M
| $152K | ﹤0.01% |
+18,500
| New | +$202K |
2026 Q1
0 quarters
|
|
11620
PUT
Nu Skin
NUS
$224M
| $152K | ﹤0.01% |
20,900
+2,400
| +13% | +$21.7K |
2013 Q2
51 quarters
|
|
11621
CALL
Stem
STEM
$41M
| $152K | ﹤0.01% |
17,200
-14,770
| -46% | -$198K |
2025 Q3
2 quarters
|
|
11622
CALL
Evolent Health
EVH
$391M
| $152K | ﹤0.01% |
66,600
+26,300
| +65% | +$83.4K |
2022 Q2
15 quarters
|
|
11623
PUT
GoodRx Holdings
GDRX
$1.12B
| $152K | ﹤0.01% |
77,400
-120,300
| -61% | -$282K |
2020 Q4
21 quarters
|
|
|
SKYA
11624
CALL
SkyAI Inc
SKYA
$79.6M
| $152K | ﹤0.01% |
+90,200
| New | +$173K |
2026 Q1
0 quarters
|
|
|
API
11625
CALL
Agora
API
$345M
| $152K | ﹤0.01% |
42,800
+29,100
| +212% | +$123K |
2025 Q4
1 quarter
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.